151 related articles for article (PubMed ID: 30793376)
1. Kidney transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity.
Grupper A; Schwartz D; Baruch R; Schwartz IF; Nakache R; Goykhman Y; Katz P; Lebedinsky A; Nachmany I; Lubezky N; Aouizerate J; Shashar M; Katchman H
Transpl Int; 2019 Jul; 32(7):730-738. PubMed ID: 30793376
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
3. Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
Nuij V; Fuhler GM; Edel AJ; Ouwendijk RJ; Rijk MC; Beukers R; Quispel R; van Tilburg AJ; Tang TJ; Smalbraak H; Bruin KF; Lindenburg F; Peyrin-Biroulet L; van der Woude CJ;
J Crohns Colitis; 2015 Nov; 9(11):997-1003. PubMed ID: 26223842
[TBL] [Abstract][Full Text] [Related]
4. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
5. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
Schnitzler F; Friedrich M; Stallhofer J; Schönermarck U; Fischereder M; Habicht A; Karbalai N; Wolf C; Angelberger M; Olszak T; Beigel F; Tillack C; Göke B; Zachoval R; Denk G; Guba M; Rust C; Grüner N; Brand S
PLoS One; 2015; 10(8):e0135807. PubMed ID: 26288187
[TBL] [Abstract][Full Text] [Related]
6. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.
Riley TR; Schoen RE; Lee RG; Rakela J
Am J Gastroenterol; 1997 Feb; 92(2):279-82. PubMed ID: 9040206
[TBL] [Abstract][Full Text] [Related]
7. Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis.
Rabian F; Porcher R; Sicre de Fontbrune F; Lioure B; Laplace A; Nguyen S; Tabrizi R; Vigouroux S; Tomowiak C; Maillard N; Suarez F; Delage J; Peffault de Latour R; Socié G;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1721-1724. PubMed ID: 27246370
[TBL] [Abstract][Full Text] [Related]
8. The clinical outcomes of second kidney transplantation in IgA nephropathy: a multicenter retrospective study.
Baek CH; Lee JG; Park JH; Kim H; Yang WS; Kim YS; Huh WS; Yang J; Han DJ; Park SK
Clin Nephrol; 2016 Aug; 86(2):87-93. PubMed ID: 27345187
[TBL] [Abstract][Full Text] [Related]
9. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
11. The association of discharge decisions after deceased donor kidney transplantation with the risk of early readmission: Results from the deceased donor study.
Harhay MN; Jia Y; Thiessen-Philbrook H; Besharatian B; Gumber R; Weng FL; Hall IE; Doshi M; Schroppel B; Parikh CR; Reese PP
Clin Transplant; 2018 Apr; 32(4):e13215. PubMed ID: 29393541
[TBL] [Abstract][Full Text] [Related]
12. Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.
Papamichael K; Chachu KA; Vajravelu RK; Vaughn BP; Ni J; Osterman MT; Cheifetz AS
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1580-1588.e3. PubMed ID: 28365486
[TBL] [Abstract][Full Text] [Related]
13. Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.
Ungar B; Levy I; Yavne Y; Yavzori M; Picard O; Fudim E; Loebstein R; Chowers Y; Eliakim R; Kopylov U; Ben-Horin S
Clin Gastroenterol Hepatol; 2016 Apr; 14(4):550-557.e2. PubMed ID: 26538204
[TBL] [Abstract][Full Text] [Related]
14. Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
Ribaldone DG; Vieujean S; Julsgaard M; Armandi A; Zingone F; Savarino E; Cañete F; Aratari A; Imperatore N; Ramos L; Plaza R; Pugliese D; Barberio B; Drobne D; Chaparro M
J Crohns Colitis; 2023 Jul; 17(7):1097-1102. PubMed ID: 36815684
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA Nephropathy.
Oki R; Unagami K; Kakogawa J; Beppu H; Banno T; Yagisawa T; Kanzawa T; Hirai T; Omoto K; Kitajima K; Shirakawa H; Hoshino J; Takagi T; Ishida H
Transpl Int; 2023; 36():11220. PubMed ID: 37213487
[TBL] [Abstract][Full Text] [Related]
16. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
[TBL] [Abstract][Full Text] [Related]
17. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
18. Outcome of renal transplantation in different primary diseases.
Lim EC; Terasaki PI
Clin Transpl; 1991; ():293-303. PubMed ID: 1820124
[TBL] [Abstract][Full Text] [Related]
19. Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study.
Choi HY; Huh KH; Lee JG; Song MK; Kim MS; Kim YS; Kim BS
PLoS One; 2016; 11(12):e0168337. PubMed ID: 27973553
[TBL] [Abstract][Full Text] [Related]
20. Single-center long-term results of renal transplantation for IgA nephropathy.
Bumgardner GL; Amend WC; Ascher NL; Vincenti FG
Transplantation; 1998 Apr; 65(8):1053-60. PubMed ID: 9583865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]